Article Details
Retrieved on: 2021-04-06 12:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Artiva's pipeline includes AB-101, an ADCC enhancer NK-cell therapy for use in combination with monoclonal antibodies or innate-cell engagers.
Article found on: www.oaoa.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here